ArticleCancer immunology, immunotherapy : CII2024

Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma.

Sophia Stock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.